ZLZhenbao Li

Zhenbao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhenbao Li has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Jiaqiang Liu

    Department of Neurosurgery, The Translational Research Institute for Neurological Disorders of Wannan Medical College The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) Wuhu Anhui China

    7 shared publications
  • Zihuan Zhang

    Department of Neurosurgery, The Translational Research Institute for Neurological Disorders of Wannan Medical College The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) Wuhu Anhui China

    6 shared publications
  • Feiyun Qin

    Department of Neurosurgery, The Translational Research Institute for Neurological Disorders of Wannan Medical College The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) Wuhu Anhui China

    5 shared publications
  • Xintong Zhao

    Department of Neurosurgery, The Translational Research Institute for Neurological Disorders of Wannan Medical College The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College) Wuhu Anhui China

    5 shared publications
  • Niansheng Lai

    Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

    3 shared publications
  • Bingbing Zhang

    Department of Neurosurgery, The First Affiliated Hospital of Wannan Medical College, 2 Zheshan Road, Wuhu, Anhui Province, 241001, P.R. China

    2 shared publications

Latest Publications

  • Open Access

    Exosomes miR‐369‐3p Alleviates Early Brain Injury After Subarachnoid Hemorrhage by Promoting Ferroptosis of M1 Microglia via Inhibiting iNOS/GPX4 Axis

    by Jian Fang, Feiyun Qin, Pengcheng Xu, Xintong Zhao, Zihuan Zhang, Dayong Xia, Jiaqiang Liu, Jiajia Yu, Liying Hu, Yuchen Wang, et al.

    Background: Ferroptosis in pathophysiological mechanisms in early brain injury after subarachnoid hemorrhage (SAH‐EBI) has been demonstrated. MicroRNAs (miRNAs) are involved in various aspects of neurological disorders. A growing number of studies suggest that intense inflammation mediated by M1 microglia after subarachnoid hemorrhage (SAH) may lead to neurological damage. According to our research and related reports, exosomal miR‐369‐3p is involved in the pathophysiological process of SAH, and miR‐369‐3p has a potentially central role in regulating inflammatory responses. Therefore, targeted delivery of miR‐369‐3p across the blood‐brain barrier (BBB) into the brain to alleviate SAH‐EBI is a promising therapeutic approach. Methods: In this study, we extracted exosomes from RBCs and then modified RVG peptide onto the exosome surface using the click chemistry principle. Finally, miR‐369‐3p mimic was loaded into the RVG peptide‐modified exosomes to form RVG‐Exo/miR‐369‐3p (RVG‐Exo/miR) by electroporation. Tail vein injection of RVG‐Exo/miR was used to achieve delivery of miR‐369‐3p into the brain of SAH mice. The effect of miR‐369‐3p on SAH‐EBI was examined by neurobehavioral scores, brain water content, Fluoro‐Jade C (FJC) staining, and Nissl staining. MDA and GSH kits were used to assess the extent of ferroptosis occurrence. Western blotting analysis, immunofluorescence staining, and qRT‐PCR were used to detect the levels of each protein, mRNA, and miRNA. Results: The exosome system (RVG‐Exo/miR) successfully delivered miR‐369‐3p to the mouse central nervous system across the blood‐brain barrierBBB. This exosomal system reduced the number of M1 microglia by enhancing their sensitivity to ferroptosis by inhibiting the expression of iNOS and GPX4. In addition, miR‐369‐3p treatment alleviated neurobehavioral disorders, brain edema, and neuronal damage after SAH‐EBI. Conclusions: RVG‐Exo/miR promotes ferroptosis in M1 microglia by inhibiting the iNOS/GPX4 axis, which may be a new and effective therapeutic strategy for treating SAH‐EBI.


  • Retrospective Analysis of the Clinical Efficacy of Middle Meningeal Artery Embolization Combined With Burr-Hole Drainage in the Treatment of Chronic Subdural Hematoma

    by Dayong Xia, Jiaqiang Liu, Fei Msc Ding, Zhengqing Msc Hu, Feiyun Msc Qin, Zihuan Zhang, Niansheng Lai, Yuelong Msc Jin, Zhenbao Msc Li

    Objective: To investigate the therapeutic efficacy of middle meningeal artery (MMA) embolization combined with burr-hole drainage in chronic subdural hematoma (CSDH), to establish an evidence base for clinical decision-making. Methods: A retrospective analysis was conducted on 82 CSDH patients who underwent surgical intervention at The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) between July 2021 and June 2023. Patients were divided into 2 groups: the control group (burr-hole drainage alone, n=56) and the study group (MMA embolization combined with burr-hole drainage, n=26). Preoperative hematoma volume, age, sex, platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (APTT), modified Rankin Scale (mRS) scores (preoperative and postoperative), and postoperative hematoma clearance rates were compared between the 2 groups. Results: No statistically significant differences were observed in baseline characteristics (age, sex, PLT, PT, APTT), preoperative hematoma volume, or preoperative mRS scores between the 2 groups (all P >0.05). The study group demonstrated significantly better postoperative mRS scores (≤2 points) compared with the control group ( P P <0.05). Conclusion: MMA embolization combined with burr-hole drainage is a safe and effective approach for CSDH treatment, reducing hematoma recurrence and improving patient prognosis.


  • Open Access

    TREM2 Alleviates Subarachnoid Hemorrhage-Induced Brain Injury through Attenuating Neuroinflammation and Programmed Cell Death in Vivo and in Vitro

    by Jiaqiang Liu, Zihuan Zhang, Mengliang Zhou, Shizhang Ling, Xiaoming Zhou, Bin Yuan, Xintong Zhao, Min Qi, Yanling Han, Feiyun Qin, et al.

    Background: Apoptosis and pyroptosis are two types of programmed cell death related to the neuroinflammatory reaction after subarachnoid hemorrhage (SAH). Research indicates that triggering receptor expressed on myeloid cells 2 (TREM2) can regulate the SAH-induced inflammatory response. However, whether TREM2 regulates programmed cell death (apoptosis and pyroptosis) remains to be clarified. The purpose of the present study was to investigate the effects of TREM2 on cell death in SAH. Methods: SAH was induced in adult male C57BL/6J mice by endovascular perforation. An in-vitro cellular model of SAH was established by treating cocultured BV2 microglia and HT22 neuronal cells with oxyhemoglobin. TREM2 overexpression or knockdown was carried out by intraventricular lentivirus injection at 7 d before SAH induction in mice or lentiviral transfection, respectively. Neurobehavioral tests as well as western blot, reverse transcription–quantitative polymerase chain reaction (RT-qPCR), immunofluorescence, Evans blue (EB) staining, Nissl staining, and flow cytometry assays were performed to investigate the neuroprotective role of TREM2 after SAH. Results: After SAH, the TREM2 mRNA and protein levels were elevated in SAH mice, exhibiting a peak at 72 h. TREM2 overexpression improved the SAH-induced neurological deficits in mice, while TREM2 knockdown worsened them. In the brains of mice with TREM2 overexpression, less neuronal death and more neuronal survival were detected at 72 h post SAH. Meanwhile, TREM2 overexpression showed an inhibitory effect on microglial activation, neutrophil infiltration, and the expression of cell death marker proteins. Consistent results were obtained in vitro. Conclusions: Our research indicates the important role of TREM2 on cell death after SAH, suggesting that targeting TREM2 might be an effective approach for treating SAH.


  • Open Access

    Safety and effectiveness of double microcatheter technique in the treatment of ruptured aneurysms of anterior cerebral circulation

    by Xintong Zhao, Zihuan Zhang, Jiaqiang Liu, Feiyun Qin, Liying Hu, Zhenbao Li

    Objective: To evaluate the safety and effectiveness of the double microcatheter technique in the treatment of ruptured aneurysms of the anterior cerebral circulation.Methods: Between 2012 and 2019, 113 patients with ruptured aneurysms of the anterior cerebral circulation were treated using the double microcatheter technique. Clinical records, angiographic results, and procedure-related complications were reviewed. Clinical and angiographic follow-up was performed.Results: Complete occlusion, neck remnant, and partial occlusion were, respectively, recorded in 56.6, 38.9, and 4.4% of the total cases. For all patients, the incidence of intraoperative complications was 5.3% (6/113), and the overall rate of morbidity was 10.6% (12/113). Before discharge, three patients (2.7%) died. There was no procedure-related mortality. At discharge, favorable outcomes were observed in 79.6% (90/113) of the patients. High Hunt-Hess grades and receiving a craniotomy or external ventricular drainage were risk factors for clinical outcomes at discharge. Clinical follow-up was performed in 91 patients at a mean interval of 14.07 ± 11.68 months. At follow-up, favorable outcomes were observed in 92.3% (84/91) of the patients. Angiographic follow-up was performed in 66 patients at an average of 11.53 ± 11.13 months. The recurrence rate was 37.9%. Of these patients, 13 (19.7%) received retreatment.Conclusion: The double microcatheter technique can be performed in ruptured aneurysms with high technical success and low morbidity/mortality. However, recurrence remains a problem, and patients should be followed up regularly.


  • Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study

    by Zhenbao Li, Jianwei Xuan, Xinggen Fang, Xintong Zhao, Bingbing Zhang, Degang Wu, Niansheng Lai, Jiaqiang Liu, Zihuan Zhang, Jinlong Yuan, et al.

    Aim: To investigate the effectiveness and safety of the Enterprise 2 (E2) stent versus the Enterprise 1 (E1) stent in treating ruptured intracranial aneurysms (RIAs) in China. Materials & methods: The authors conducted an electronic medical record analysis for patients with RIAs who underwent E1/E2 deployment. The main outcomes were immediate complete occlusion (ICO), patient functional outcomes, complications and aneurysm recurrence. Results: Stent deployment was successful in all patients (E2: 90; E1: 270). ICO and patients with good functional outcomes at discharge were similar between E2 and E1 (80.0% vs 75.1% and 78.7% vs 81.1%, respectively). The E2 group had a significantly lower complication rate compared with the E1 group (7.8% vs 16.4%; odds ratio: 0.36; 95% CI: 0.15–0.91; p = 0.031). By 6 months post-discharge, the two groups had comparable patient functional outcomes and aneurysm recurrence (E2 vs E1: 80.2% vs 81.9% and 13.3% vs 14.9%). Conclusion: Compared with the E1 stent, the E2 stent had similar effectiveness but a lower complication risk in treating RIAs.


  • Isoliquiritigenin mitigates oxidative damage after subarachnoid hemorrhage in vivo and in vitro by regulating Nrf2-dependent Signaling Pathway via Targeting of SIRT1

    by Jia-Qiang Liu, Xin-Tong Zhao, Fei-Yun Qin, Jia-Wang Zhou, Fei Ding, Gang Zhou, Xiang-Sheng Zhang, Zi-Huan Zhang, Zhen-Bao Li


  • Open Access

    Endovascular Treatment of Ruptured Very Small Intracranial Aneurysms: Complications, Recurrence Rate, and Clinical Outcomes

    by Feiyun Qin, Jiaqiang Liu, Xintong Zhao, Degang Wu, Niansheng Lai, Zihuan Zhang, Zhenbao Li

    Objective: The aim of this study was to evaluate the safety and efficacy of endovascular treatment for ruptured very small (≤3 mm) intracranial aneurysms (VSIAs).Methods: The clinical data and imaging results for 152 patients with VSIAs treated with coil embolization from August 2014 to June 2020 were retrospectively reviewed. The influential factors related to the preoperative complications, aneurysm recurrence, and clinical outcomes for these patients were analyzed.Results: Among 152 patients with ruptured VSIAs, 90 were treated with coil embolization alone, while 62 were treated with stent-assisted coil embolization. Eighteen patients experienced intra and/or postoperative complications (overall incidence = 11.8%). One person died of intraoperative aneurysm re-rupture and postoperative rebleeding (mortality rate = 0.65%). Twenty patients had various degrees of neurological dysfunction (morbidity rate = 13.1%). Statistical analysis showed that there was no independent risk factor associated with perioperative complications. The rate of complete aneurysm occlusion at discharge and follow-up was 76.3 and 86.2%, respectively. A total of 105 patients underwent digital subtraction angiography during follow-up, and 18 of them experienced postoperative recurrence (recurrence rate = 17.1%). Seven patients were retreated (retreatment rate = 6.7%). The use of stents was the only factor that affected the postoperative recurrence of aneurysm. The incidence of favorable clinical outcomes (Glasgow Outcome Scale score ≥ 4) at discharge and follow-up was 86.2 and 97.1%, respectively. Univariate analysis showed that the preoperative Hunt-Hess grade, CT Fisher grade, and perioperative complications were risk factors for poor clinical outcomes. Multiple logistic regression analysis showed that perioperative complication was the most significant risk factor for the clinical prognosis of patients with ruptured VSIAs.Conclusion: Endovascular treatment is a safe and efficient approach for ruptured VSIAs. Stent-assisted coiling reduced the recurrence rate of aneurysm without increasing the incidence of perioperative complications. The Hunt-Hess grade, CT Fisher grade, and perioperative complications were independent factors associated with the clinical outcomes of patients with ruptured VSIAs, and perioperative complication was the most significant risk factor for poor prognosis in patients.


  • Open Access

    A Modified Treatment Through Point-to-Point Coil Embolization for Direct Carotid Cavernous to Fistula: A Single-Center Result

    by Zihuan Zhang, Jiaqiang Liu, Bingbing Zhang, Mengliang Zhou, Xintong Zhao, Zhenbao Li

    This study aims to assess the safety and efficacy of the modified treatment through point-to-point coil embolization of direct carotid cavernous fistula (dCCF), and evaluate the long-term outcome of patients who underwent the above treatment. A total of 18 patients who suffered from dCCF (a total of 19 fistulas) between January 2013 to May 2020 were analyzed. Among these patients, 14 patients were treated through point-to-point coil embolization of the fistula, while four patients were treated through combined endovascular embolization (coils, a balloon, Onyx, and/or a stent). The number of coils that filled the fistulas was counted. The primary outcome was defined by post-operative digital subtraction angiography (DSA) or the signs after the recanalization of dCCFs during the follow-up period. For patients with dCCF who underwent point-to-point coil embolization, a minimum of three coils and a maximum of 16 coils were used for these 14 fistula patients, and an average of 7.9 coils were used for each fistula, but none of the fistulas was recanalized. Furthermore, two pseudoaneurysms were observed as a result of the compression of the coils. However, none of these 14 patients presented with signs of recanalization of fistulas or cranial paralysis. The procedure applied for the present study was shown to be a safe, economical and efficacious treatment approach for dCCFs through the point-to-point coil embolization of the fistula.